# Former Arab Republic of Yemen Chemicals Export Opportunities (HS 28-38)

![Yugalinks](https://www.yugalinks.com/trade/yugalinks-logo-v3-dark-mode.webp)

> Yugalinks sector export playbook

Explore Former Arab Republic of Yemen HS 28-38 chemicals export opportunities, product portfolio, buyer markets, growth signals, and diversification opportunities.

## Overview

- Exporter: Former Arab Republic of Yemen (YEM)
- Sector: Chemicals
- HS chapters: HS 28-38
- Latest trade year: 2024
- Sector exports: $1.3M
- Products: 13
- Buyer markets: 22
- Average CAGR: +4.7%
- Global sector size: $311.1B

## Product portfolio

| Product | Global size | Your exports | Opportunity | CAGR | Markets | Share |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| HS 300490 - Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $237.4B | $552.6K | $84.4B | +5.3% | 15 | +0.0% |
| HS 330499 - Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations) | $27.3B | $191.0K | $11.3B | -1.5% | 10 | +0.0% |
| HS 382499 - Chemical products, mixtures and preparations: n.e.c. heading 3824 | $18.1B | $64.4K | $11.1B | -9.6% | 5 | +0.0% |
| HS 330300 - Perfumes and toilet waters | $13.9B | $25.7K | $8.2B | -8.1% | 8 | +0.0% |
| HS 382200 - Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | $6.9B | $57.7K | $3.0B | +34.0% | 3 | +0.0% |
| HS 340220 - Washing and cleaning preparations: surface-active, whether or not containing soap (excluding those of heading no. 3401), put up for retail sale | $1.1B | $4.7K | $718.9M | +12.7% | 1 | +0.0% |
| HS 280920 - Phosphoric acid and polyphosphoric acids | $417.4M | $18.3K | $714.7M | +22.7% | 1 | +0.0% |
| HS 284440 - Radioactive elements, isotopes, compounds, n.e.c. in heading no. 2844 alloys, dispersions (including cermets), ceramic products and mixtures containing these elements, isotopes or compounds: radioactive residues | $927.2M | $11.5 | $685.2M | -17.6% | 1 | +0.0% |
| HS 300290 - Toxins, cultures of micro-organisms (excluding yeasts) and similar products | $1.2B | $3.7 | $653.3M | -83.9% | 1 | +0.0% |
| HS 350691 - Adhesives: prepared, based on polymers of heading 3901 to 3913 or on rubber | $1.2B | $15.6 | $489.4M | +77.8% | 1 | +0.0% |
| HS 300439 - Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | $824.6M | $358.6K | $443.6M | +140.5% | 1 | +0.2% |
| HS 330590 - Hair preparations: n.e.s. in heading no. 3305 | $1.3B | $8.6K | $397.5M | +4.3% | 1 | +0.0% |
| HS 330210 - Odoriferous substances and mixtures: of a kind used in the food or drink industries | $404.1M | $22.8 | $394.6M | +21.8% | 1 | +0.0% |

## Best markets

- USA, Puerto Rico and US Virgin Islands (USA): $30.0B calculated opportunity across 7 products.
- Switzerland, Liechtenstein (CHE): $27.7B calculated opportunity across 1 products.
- Germany (DEU): $9.1B calculated opportunity across 5 products.
- China (CHN): $8.3B calculated opportunity across 4 products.
- United Kingdom (GBR): $7.3B calculated opportunity across 4 products.
- Belgium (BEL): $7.0B calculated opportunity across 1 products.
- Netherlands (NLD): $6.5B calculated opportunity across 3 products.
- Italy (ITA): $6.0B calculated opportunity across 3 products.
- Canada (CAN): $4.9B calculated opportunity across 2 products.
- France (FRA): $3.1B calculated opportunity across 1 products.
- Saudi Arabia (SAU): $1.9B calculated opportunity across 4 products.
- Singapore (SGP): $1.8B calculated opportunity across 2 products.

## Growth stars

- HS 300439: +140.5% average CAGR, $443.6M calculated opportunity.
- HS 350691: +77.8% average CAGR, $489.4M calculated opportunity.
- HS 382200: +34.0% average CAGR, $3.0B calculated opportunity.
- HS 280920: +22.7% average CAGR, $714.7M calculated opportunity.
- HS 330210: +21.8% average CAGR, $394.6M calculated opportunity.
- HS 340220: +12.7% average CAGR, $718.9M calculated opportunity.
- HS 300490: +5.3% average CAGR, $84.4B calculated opportunity.
- HS 330590: +4.3% average CAGR, $397.5M calculated opportunity.
- HS 330499: -1.5% average CAGR, $11.3B calculated opportunity.
- HS 330300: -8.1% average CAGR, $8.2B calculated opportunity.

## Diversification opportunities

- HS 300490: 15 buyer markets, $84.4B calculated opportunity.
- HS 330499: 10 buyer markets, $11.3B calculated opportunity.
- HS 330300: 8 buyer markets, $8.2B calculated opportunity.
- HS 382499: 5 buyer markets, $11.1B calculated opportunity.
- HS 382200: 3 buyer markets, $3.0B calculated opportunity.
- HS 340220: 1 buyer markets, $718.9M calculated opportunity.
- HS 280920: 1 buyer markets, $714.7M calculated opportunity.
- HS 284440: 1 buyer markets, $685.2M calculated opportunity.
- HS 300290: 1 buyer markets, $653.3M calculated opportunity.
- HS 350691: 1 buyer markets, $489.4M calculated opportunity.

## Method

Reported trade observations and calculated indicators are shown separately. Validate buyers, standards, logistics, pricing, and competition before acting. [Read the Yugalinks methodology](https://www.yugalinks.com/methodology).

## Data sources

- Primary trade series: OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). [OECD Data Explorer](https://data-explorer.oecd.org/) - [OECD Terms & Conditions](https://www.oecd.org/termsandconditions/)
- CEPII BACI bilateral trade flows (202601): [dataset page](https://www.cepii.fr/CEPII/en/bdd_modele/bdd_modele_item.asp?id=37) - [BACI documentation](https://www.cepii.fr/DATA_DOWNLOAD/baci/doc/baci_webpage.html) - [Etalab 2.0 Open Licence](https://www.etalab.gouv.fr/wp-content/uploads/2018/11/open-licence.pdf)

This page presents derived Yugalinks views of reported observations and calculated indicators.
